`
`Allergan - NYSE: AGN - Company Profile - Allergan
`
`-2:-,:.i-I-Allergan..
`
`Company Profile
`
`Leading Growth Pharma
`
`Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader
`in a new industry model — Growth Pharma. Allergan is focused on developing, manufacturing and commercializing
`branded pharmaceuticals, devices and biologic products for patients around the world.
`
`Allergan markets a portfolio of leading brands and best—in-class products for the central nervous system, eye care,
`medical aesthetics and dermatology, gastroenterology, women's health, urology and anti—infective therapeutic
`categories.
`
`Open Science
`
`Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to
`identifying and developing game—changing ideas and innovation for better patient care. This approach has led to
`Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid—to—late
`stage pipeline programs in development.
`
`16,000 Employees
`
`Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life.
`
`Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world
`
`by always doing what is right.
`
`100 Countries
`
`With commercial operations in approximately 100 countries, Allergan is committed to working with physicians,
`
`healthcare providers and patients to deliver innovative and meaningful treatments that help people around the
`
`world live longer, healthier lives.
`
`This site uses cookies to give you the best possible experience, By browsing our website, you agree to our use of
`cookies. - Read more
`
`https://www.a||ergan.cornlaboulloom pany-profile
`
`1/3
`
`1
`
`ALL 2031
`MYLAN PHARMACEUTICALS v. ALLERGAN
`|PR2016-01128
`
`1
`
`ALL 2031
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`
`
`3/16/2017
`
`Allergan - NYSE: AGN - Company Profile - Allergan
`
`
`
`https ://www.a| |ergan.com/aboutlcom pany- profi Ie
`
`
`
`2
`
`
`
`3/16/2017
`
`Allergan - NYSE: AGN - Company Profile - Allergan
`
`https ://www.a| |ergan.com/aboutlcom pany- profi Ie
`
`3/3
`
`3
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
